semaglutide subcutaneous or intramuscular NAD+ Injections: Benefits, Types, and What to Expect Intramuscular and Subcutaneous Injections -

10.1007/s40256-024-00647-3 7

A study of overweight patients over 45 without diabetes and with heart disease published in the New England Journal of Medicine concluded that a weekly dosage of 2.4 mg of semaglutide decreased the incidence of death from cardiovascular causes

In one study, participants who completed an eight-week mental training program showed a 26 percent increase in plasma BDNF, compared to a 13 percent decline in the control group

It might relate to how the medication affects gut motility and water absorption in your intestines

Maintaining adequate hydration is particularly important during the initial titration period when gastrointestinal symptoms are most common